David Qualls

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Characteristics and outcomes of patients with double refractory and double exposed chronic lymphocytic leukemia”.

Characteristics and outcomes of patients with double refractory and double exposed chronic lymphocytic leukemia

Blood Advances(2025)10.1182/bloodadvances.2025016006

N/A

0.385DataRank · unranked

12 citations

Yinglu Zhou, Mariia Mikhaleva, Daniel Choi, Stacey M. Fernandes, Philippe Armand +20 more

CD19-directed chimeric antigen receptor T cell therapy in Waldenström macroglobulinemia: a preclinical model and initial clinical experience

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2021-004128

N/A

0DataRank · unranked

36 citations

David Qualls, Sébastien Monette, Shenon Sethi, Ahmet Doǧan, Mikhail Roshal +8 more

Prospects in the management of patients with follicular lymphoma beyond first-line therapy

Haematologica(2022)10.3324/haematol.2021.278717

N/A

0DataRank · unranked

28 citations

Gilles Salles, David Qualls

A phase 1 trial of copanlisib plus ibrutinib in relapsed/refractory mantle cell lymphoma

Blood Advances(2022)10.1182/bloodadvances.2021006555

N/A

0DataRank · unranked

6 citations

Hiu Ying Lam, Karissa Whiting, Anita Kumar, Matthew J. Matasar, Colette Owens +10 more

Impaired humoral immunity is associated with prolonged COVID-19 despite robust CD8 T cell responses

Cancer Cell(2022)10.1016/j.ccell.2022.05.013

N/A

0DataRank · unranked

46 citations

Justin Kim, David Qualls, Madeline A. Hwee, Ya-Hui Lin, Sawsan R. Boutemine +15 more

Tafasitamab and lenalidomide in large B-cell lymphoma: real-world outcomes in a multicenter retrospective study

Blood(2023)10.1182/blood.2023021274

N/A

0DataRank · unranked

47 citations

Nicholas Lambert, Paolo F. Caimi, Mwanasha H. Merrill, Priyanka Pullarkat, Richard Godby +19 more

Molecularly targeted epigenetic therapy with mocetinostat in relapsed and refractory non-Hodgkin lymphoma with CREBBP or EP300 mutations: an open label phase II study

Leukemia & lymphoma/Leukemia and lymphoma(2023)10.1080/10428194.2022.2164194

N/A

0DataRank · unranked

9 citations

Ariela Noy, David J. Straus, Matthew J. Matasar, Craig H. Moskowitz, Venkatraman Seshan +6 more

Retrospective characterization of nodal marginal zone lymphoma

Blood Advances(2023)10.1182/bloodadvances.2022009587

N/A

0DataRank · unranked

8 citations

Esther Drill, David Qualls, Michelle Okwali, Connie Lee Batlevi, Philip Caron +24 more

Long‐term outcomes of patients with limited‐stage ocular adnexal DLBCL treated with combined modality therapy in the rituximab era

British Journal of Haematology(2022)10.1111/bjh.18590

N/A

0DataRank · unranked

2 citations

Brandon S. Imber, Michelle Okwali, Paul A. Hamlin, Anita Kumar, Oscar Lahoud +11 more